Lyell Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Jounce Therapeutics and Agenus.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Jounce Therapeutics
Jounce Therapeutics
Jounce Therapeutics is a clinical-stage immunotherapy company.
Agenus
Agenus
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
Founding Date
Founding Date
2018
Founding Date
2013
Founding Date
1994
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
Cambridge, US HQ
Locations
Lexington, US HQ
Cambridge, GB
Emeryville, US
Berkeley, US
Vacaville, US
Employees
Employees
188
Employees
1302% increase
Employees
8174% decrease
Valuation ($)
Valuation ($)
243.3 m
Valuation ($)
101.6 m
Valuation ($)
96.2 m

Financial

Revenue (est.)
Revenue (est.)
$36k (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$114.2m (FY, 2025)
Net income
Net income
($274.4m) (FY, 2025)
Net income
($50.9m) (FY, 2022)
Net income
($3.1m) (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 103m
Total funding raised
$ 171.1m
For sources of this data, please see the company profile

View Company Profiles

Jounce Therapeutics
HQ
Cambridge, US
Employees
130↑ 2% increase

Jounce Therapeutics is a clinical-stage immunotherapy company.

View company
Agenus
HQ
Lexington, US
Employees
81

Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.

View company